Seller record · Telehealth service

Novi

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The home page refers to licensed US pharmacies, and the terms and the medical consent refer only to pharmacy network providers and a pharmacist in charge. 2 more criteria also fail; see the table below.

At a glance

NoviTelehealth service

5/8criteria passed

Price: GLP-1 plans from $133 a month in an offer, was $299
Sells: semaglutide injections, tirzepatide injections, Mounjaro, and 3 more
FDA letters: None on file

Visit Novi See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A self-pay telehealth weight loss service selling semaglutide and tirzepatide injections at one price for every dose, and branded Mounjaro, Ozempic, Wegovy and Zepbound at a higher price. Care starts with a free online evaluation reviewed by a licensed clinician, and its pages never say whether the lower-priced injections are compounded.

Operating entity Novi International LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Novi's website; Novi's terms of service page
S2	Prescription gating	PASS	Novi's website
S3	Pharmacy identification	FAIL	Novi's website; Novi's terms of service page; Novi's medical consent
S4	Compounding disclosure	FAIL	Novi's website; Novi's terms of service page; Novi's medical consent
S5	Analytical documentation	FAIL	Novi's website; Novi's terms of service page; Novi's medical consent
S6	Business address	PASS	Novi's privacy policy; Novi's privacy practices page; Novi's terms of service page
S7	Price disclosure	PASS	Novi's website; Novi's terms of service page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews each intake and writes the prescription only if appropriate, and the terms say the providers may deny care.Source: Novi's website; Novi's terms of service page.

S2PASSThe home page lists a free two-minute online evaluation reviewed by the licensed medical team as the first step, with the plan and the prescription only after approval, and every start button points to that evaluation.Source: Novi's website.

S3FAILNo filling pharmacy is named. The home page refers to licensed US pharmacies, and the terms and the medical consent refer only to pharmacy network providers and a pharmacist in charge.Source: Novi's website; Novi's terms of service page; Novi's medical consent.

S4FAILThe home page sells semaglutide and tirzepatide injections at one price for every dose and prices the branded pens separately, and no page, including the terms, the privacy policies and the medical consent, says whether the injections are compounded or that compounded drugs are not FDA-approved. The answers say GLP-1s are FDA-approved for weight management.Source: Novi's website; Novi's terms of service page; Novi's medical consent.

S5FAILNo certificate of analysis or lot document is published on the home page, the terms or the medical consent.Source: Novi's website; Novi's terms of service page; Novi's medical consent.

S6PASS4131 N Central Expressway #900, Dallas, TX 75204, printed in the privacy policy and in the notice of privacy practices. The terms name the operator as Novi International LLC and name Texas law, and other pages use Novi Health LLC and Novi Health International, LLC.Source: Novi's privacy policy; Novi's privacy practices page; Novi's terms of service page.

S7PASSThe home page prints GLP-1 treatment starting at $133 a month beside a struck-through $299, with a countdown to a price increase, the same at every dose and including the consult, prescription and shipping. Semaglutide and tirzepatide injections are offered at up to $200 and $250 off, and Mounjaro, Ozempic, Wegovy and Zepbound from $1500. The terms require a minimum of three consecutive months on a subscription.Source: Novi's website; Novi's terms of service page.

S8PASSNo FDA warning letter names Novi, Novi International LLC or Novi Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injections, tirzepatide injections, Mounjaro, Ozempic, Wegovy, Zepbound.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Novi

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.